FDA Inspection 987430 — Apollo Renal Therapeutics, LLC

Apollo Renal Therapeutics, LLC — FEI 3010032115

The FDA completed an inspection of Apollo Renal Therapeutics, LLC on September 9, 2016 in Ocala, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Ocala, FL (United States)